Exome sequencing of patients with extreme toxicities to uncover pharmacogenomics of 5-fluorouracil-based chemotherapeutics in colorectal cancer

被引：0

作者：

Simoes, Ana ^{[1
]}

Lopez Doldan, Carmen ^{[2
]}

Duran-Pineiro, Goretti ^{[1
]}

Fernandez-Montes, Ana ^{[3
]}

Garcia-Gomez, Jesus ^{[3
]}

Fernandez-Gonzalez, Maria Perfecta ^{[2
]}

Salgado-Fernandez, Mercedes ^{[3
]}

Paez, David ^{[4
,5
,6
]}

Guino, Elisabet ^{[7
]}

Lopez-Fernandez, Luis ^{[8
]}

Rojas, Augusto ^{[9
]}

Castells, Antoni ^{[10
]}

Castellvi-Bel, Sergi ^{[10
]}

Ruiz-Ponte, Clara ^{[1
,11
]}

Vymetalkova, Veronika ^{[12
]}

Vodicka, Pavel ^{[12
]}

Garcia de Santiago, Belen ^{[13
]}

Lopez-Aspiroz, Elena ^{[13
]}

Garcia-Mata, Jesus ^{[3
]}

Carracedo, Angel ^{[1
,11
]}

Fernandez-Rozadilla, Ceres ^{[1
]}

机构：

[1] Inst Invest Sanitaria Santiago, Santiago De Compostela, Spain

[2] Complexo Hosp Univ Ourense, Oncol Pharm, Orense, Spain

[3] Complexo Hosp Univ Ourense, Oncol, Orense, Spain

[4] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[5] Med Sci Innovat Res, Barcelona, Spain

[6] Univ Autonoma Barcelona, Barcelona, Spain

[7] Inst Catala Oncol, Barcelona, Spain

[8] Hosp Gen Univ Gregorio Maranon, Dept Pharm, Madrid, Spain

[9] Tecnol Monterrey, Sch Med & Hlth Sci, Monterrey, Mexico

[10] Inst Invest Biomed August Pi & Sunyer, Dept Gastroenterol, Barcelona, Spain

[11] Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain

[12] Charles Univ Prague, Inst Biol & Med Genet, Prague, Czech Republic

[13] Hosp Univ Infanta Sofia, Hosp Pharm Serv, Madrid, Spain

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2023年 / 31卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

EP19.003

引用

页码：300 / 300

页数：1

共 50 条

[21] Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer
PD Peppercorn
RH Reznek
P Wilson
ML Slevin
RK Gupta
British Journal of Cancer, 1998, 77 : 2008 - 2011
[22] Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer:: a pooled analysis of clinical trials
Folprecht, G
Cunningham, D
Ross, P
Glimelius, B
Di Costanzo, F
Wils, J
Scheithauer, W
Rougier, P
Aranda, E
Hecker, H
Köhne, CH
ANNALS OF ONCOLOGY, 2004, 15 (09) : 1330 - 1338
[23] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
Pan Xie
Jun-Luan Mo
Jin-Hong Liu
Xi Li
Li-Ming Tan
Wei Zhang
Hong-Hao Zhou
Zhao-Qian Liu
Cellular Oncology, 2020, 43 : 989 - 1001
[24] Influence of regulatory NLRC5 variants on colorectal cancer survival and 5-fluorouracil-based chemotherapy
Catalano, Calogerina
da Silva Filho, Miguel I.
Jiraskova, Katerina
Vymetalkova, Veronika
Levy, Miroslav
Liska, Vaclav
Vycital, Ondrej
Naccarati, Alessio
Vodickova, Ludmila
Hemminki, Kari
Vodicka, Pavel
Weber, Alexander N. R.
Foersti, Asta
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (08) : 838 - 842
[25] GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
Wang, Zaozao
Jiang, Beihai
Chen, Lei
Di, Jiabo
Cui, Ming
Liu, Maoxing
Ma, Yiyuan
Yang, Hong
Xing, Jiadi
Zhang, Chenghai
Yao, Zhendan
Zhang, Nan
Dong, Bin
Ji, Jiafu
Su, Xiangqian
JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
[26] Prognostic predictors in breast cancer patients with postoperative 5-fluorouracil-based chemotherapy
Hakamada, Y
Tsuchida, A
Arima, M
Kubouchi, T
Tokita, H
Ota, D
Kaise, H
Aoki, T
Kusama, M
Aoki, T
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 16 (02) : 309 - 314
[27] Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan
Etienne-Grimaldi, Marie-Christine
Bennouna, Jaafar
Formento, Jean-Louis
Douillard, Jean-Yves
Francoual, Mireille
Hennebelle, Isabelle
Chatelut, Etienne
Francois, Eric
Faroux, Roger
El Hannani, Chaza
Jacob, Jacques-Henri
Milano, Gerard
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (05) : 776 - 785
[28] Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer:: results of a multivariate analysis of 3825 patients
Köhne, CH
Cunningham, D
Di Costanzo, F
Glimelius, B
Blijham, G
Aranda, E
Scheithauer, W
Rougier, P
Palmer, M
Wils, J
Baron, B
Pignatti, F
Schöffski, P
Micheel, S
Hecker, H
ANNALS OF ONCOLOGY, 2002, 13 (02) : 308 - 317
[29] 5-Fluorouracil-related Cardiotoxicity; Findings From Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer
Abdel-Rahman, Omar
CLINICAL COLORECTAL CANCER, 2019, 18 (01) : 58 - 63
[30] Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer
Patel, Prapti A.
ANTI-CANCER DRUGS, 2011, 22 (04) : 311 - 316

← 1 2 3 4 5 →